Supplementary Table 2

Clinical characteristics of 35 patients with verified systemic sclerosis, grouped according to pulmonary involvement and duration of disease.

Group A (n = 12)
 Group B (n = 23)



Median
 Range
 (SEM)
 Median
 Range
 (SEM)
dSSc/lSSc
 8/4

5/18


ACA/antiScl70
 0/0

14/1


Age (y)
 57
 26–75
 (4.7)
 49
 25–76
 (2.8)
 ns
Disease duration (y)
 1
 1–1
 (0)
 2
 1–49
 (2.3)
 P < 0.01
Skin score (points)
 26
 3–36
 (3.2)
 8
 2–26
 (1.6)
 P < 0.01
VC (%p)
 77
 51–113
 (5.6)
 97
 62–148
 (3.8)
 P < 0.05
DLCO (%p)
 62
 40–90
 (4.9)
 85
 47–116
 (3.7)
 P < 0.01
PAPsyst (mmHg)
 36
 27–65
 (3.9)
 30
 18–59
 (3.4)
 ns
GFR (%p)
 103
 89–130
 (5.4)
 96
 70–136
 (4.1)
 ns
Capillary density (loops/mm)
 4.2
 2.4–6.9
 (0.6)
 5.5
 2.2–8.4
 (0.4)
 ns

DLCO, carbon monoxide-diffusing capacity; GFR, glomerular filtration rate; PAPsyst, systolic pulmonary artery pressure; VC, vital capacity. P values indicate the difference between group A and group B. ns = Not significant.

Scheja et al. Arthritis Res 2001 3:178   doi:10.1186/ar295

Open Data